腫瘤學新知 | CANCER INFORMER HONG KONG
©invincible7 / 123RF Stock Photo
©European Society for Medical Oncology
©American Society for Clinical Oncology (ASCO)
©American Association for Cancer Research
©Chinese Society for Anesthesiology
© European Society for Medical Oncology
©sherryyates / 123RF Stock Photo
The treatment of advanced and metastatic renal cell carcinoma (RCC) is at the forefront of yet another revolution. Just over a decade ago, vascular endothelial growth factor receptor (VEGFR) targeting agents such as sunitinib radically changed the treatment paradigm of RCC and have become the standard-of-care with a median overall survival (OS) nearing 30 months. Now, immunotherapy with immune checkpoint inhibitors (ICIs) is rapidly changing the treatment algorithms for patients with advanced kidney cancer.
UPPSALA, Sweden, April 24, 2019 /PRNewswire/ -- Researchers of the Erasmus University Medical Center in Rotterdam − the Netherlands, consider that the synthetic and fully resorbable TIGR® Matrix surgical mesh (Novus Scientific AB, Uppsala − Sweden) may reduce frequent risks related to the surgical repair of Sportsman's hernia.
© Copyright – MediPaper Medical Communications – Medical Communications & Health News
MediPR | MediPaper Healthcare Writers | Digital Medical Marketing | Medical Writing Solutions 醫學寫作 | Medical Writing Quote | Medical Writing Portfolio | Medical Writer Hong Kong 醫學作家香港 | Hire Healthcare Writers Hong Kong | Contact our Medical Writer Agency | MediPaper Health News | Medical Writer Jobs | MediNews.asia | Anaesthesiology.asia